Ayurcann Holdings Corp. (AYUR.CN)
CAD 0.03
(0.0%)
CAD 0.03
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -3.96 Million CAD | 25.24% |
| 2022 | -5.3 Million CAD | -71.87% |
| 2021 | -3.08 Million CAD | -1009.32% |
| 2020 | -278.36 Thousand CAD | -17.48% |
| 2019 | -236.94 Thousand CAD | -6.34% |
| 2018 | -222.81 Thousand CAD | 18.31% |
| 2017 | -272.77 Thousand CAD | -43.38% |
| 2016 | -190.24 Thousand CAD | 39.34% |
| 2015 | -313.6 Thousand CAD | -84.33% |
| 2014 | -170.13 Thousand CAD | 96.12% |
| 2013 | -4.38 Million CAD | -832.15% |
| 2012 | -469.97 Thousand CAD | -362.23% |
| 2011 | -101.67 Thousand CAD | -1395.22% |
| 2010 | -6800.00 CAD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 Q1 | -180.64 Thousand CAD | 94.28% |
| 2023 Q3 | -349.58 Thousand CAD | 54.7% |
| 2023 Q4 | -2.66 Million CAD | -662.34% |
| 2023 Q2 | -771.62 Thousand CAD | -327.15% |
| 2022 FY | -5.3 Million CAD | -71.87% |
| 2022 Q4 | -3.15 Million CAD | -198.9% |
| 2022 Q3 | -1.05 Million CAD | -536.1% |
| 2022 Q2 | -166.11 Thousand CAD | 82.55% |
| 2022 Q1 | -952.1 Thousand CAD | 23.8% |
| 2021 Q3 | -423.26 Thousand CAD | -98.86% |
| 2021 Q4 | -1.24 Million CAD | -195.21% |
| 2021 Q2 | -212.83 Thousand CAD | -270.68% |
| 2021 Q1 | 124.7 Thousand CAD | -88.01% |
| 2021 FY | -3.08 Million CAD | -1009.32% |
| 2020 Q4 | 1.04 Million CAD | 206.72% |
| 2020 Q1 | -61.66 Thousand CAD | -36.11% |
| 2020 Q2 | -39.58 Thousand CAD | 35.81% |
| 2020 FY | -278.36 Thousand CAD | -17.48% |
| 2020 Q3 | -974.61 Thousand CAD | -2362.39% |
| 2019 FY | -236.94 Thousand CAD | -6.34% |
| 2019 Q4 | -45.3 Thousand CAD | 19.46% |
| 2019 Q3 | -56.24 Thousand CAD | 23.72% |
| 2019 Q2 | -73.73 Thousand CAD | -27.68% |
| 2019 Q1 | -57.74 Thousand CAD | -38.18% |
| 2018 Q4 | -41.79 Thousand CAD | 6.96% |
| 2018 Q3 | -44.91 Thousand CAD | 42.68% |
| 2018 Q2 | -78.36 Thousand CAD | 37.95% |
| 2018 Q1 | -126.29 Thousand CAD | -197.34% |
| 2018 FY | -222.81 Thousand CAD | 18.31% |
| 2017 Q3 | -51.32 Thousand CAD | 2.55% |
| 2017 FY | -272.77 Thousand CAD | -43.38% |
| 2017 Q4 | -42.47 Thousand CAD | 17.25% |
| 2017 Q2 | -52.67 Thousand CAD | 10.54% |
| 2017 Q1 | -58.87 Thousand CAD | -7.18% |
| 2016 Q1 | -174.74 Thousand CAD | -323.79% |
| 2016 Q3 | -41.12 Thousand CAD | 8.42% |
| 2016 Q4 | -54.93 Thousand CAD | -33.56% |
| 2016 Q2 | -44.9 Thousand CAD | 74.3% |
| 2016 FY | -190.24 Thousand CAD | 39.34% |
| 2015 FY | -313.6 Thousand CAD | -84.33% |
| 2015 Q3 | -48.64 Thousand CAD | 0.69% |
| 2015 Q4 | -41.23 Thousand CAD | 15.23% |
| 2015 Q2 | -48.98 Thousand CAD | 45.87% |
| 2015 Q1 | -90.48 Thousand CAD | -118.33% |
| 2014 Q2 | 14.1 Thousand CAD | 100.35% |
| 2014 Q3 | -52.3 Thousand CAD | -470.83% |
| 2014 Q1 | -4.07 Million CAD | -4197.62% |
| 2014 Q4 | -41.44 Thousand CAD | 20.76% |
| 2014 FY | -170.13 Thousand CAD | 96.12% |
| 2013 Q3 | -121.54 Thousand CAD | -39.79% |
| 2013 Q2 | -86.94 Thousand CAD | 38.78% |
| 2013 Q4 | -94.87 Thousand CAD | 21.94% |
| 2013 Q1 | -142.02 Thousand CAD | -48.26% |
| 2013 FY | -4.38 Million CAD | -832.15% |
| 2012 Q4 | -95.8 Thousand CAD | 28.14% |
| 2012 Q3 | -133.31 Thousand CAD | -34.89% |
| 2012 Q2 | -98.82 Thousand CAD | 86.71% |
| 2012 Q1 | -743.68 Thousand CAD | -512.85% |
| 2012 FY | -469.97 Thousand CAD | -362.23% |
| 2011 FY | -101.67 Thousand CAD | -1395.22% |
| 2011 Q4 | -121.34 Thousand CAD | 91.88% |
| 2011 Q3 | -1.49 Million CAD | -4606.86% |
| 2011 Q1 | -6974.00 CAD | 57.57% |
| 2011 Q2 | -31.73 Thousand CAD | -355.08% |
| 2010 FY | -6800.00 CAD | 0.0% |
| 2010 Q4 | -16.43 Thousand CAD | 64.67% |
| 2010 Q3 | -46.52 Thousand CAD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Aion Therapeutic Inc. | -6.28 Million CAD | 36.892% |
| Blueberries Medical Corp. | -1.63 Million CAD | -142.619% |
| The BC Bud Corporation | -1.22 Million CAD | -224.147% |
| BioNxt Solutions Inc. | -7.72 Million CAD | 48.624% |
| CordovaCann Corp. | -6.88 Million CAD | 42.369% |
| Christina Lake Cannabis Corp. | -4.13 Million CAD | 3.971% |
| Captor Capital Corp. | -11.38 Million CAD | 65.137% |
| City View Green Holdings Inc. | -2.44 Million CAD | -62.042% |
| 1CM Inc. | -913.85 Thousand CAD | -334.175% |
| Global Hemp Group Inc. | -2.58 Million CAD | -53.756% |
| Greenway Greenhouse Cannabis Corporation | -4.72 Million CAD | 15.985% |
| IM Cannabis Corp. | -9.49 Million CAD | 58.226% |
| Lobe Sciences Ltd. | -4.7 Million CAD | 15.712% |
| Maple Leaf Green World Inc. | -1.09 Million CAD | -263.503% |
| Mountain Valley MD Holdings Inc. | -7.67 Million CAD | 48.269% |
| Nextleaf Solutions Ltd. | 223.33 Thousand CAD | 1876.593% |
| Ovation Science Inc. | -813.14 Thousand CAD | -387.947% |
| Pharmadrug Inc. | -13.2 Million CAD | 69.944% |
| Captiva Verde Wellness Corp. | -6.08 Million CAD | 34.796% |
| RAMM Pharma Corp. | -7.72 Million CAD | 48.611% |
| RIV Capital Inc. | -106.76 Million CAD | 96.284% |
| Revive Therapeutics Ltd. | -5.61 Million CAD | 29.382% |
| Red White & Bloom Brands Inc. | -138.89 Million CAD | 97.143% |
| SLANG Worldwide Inc. | -19.36 Million CAD | 79.512% |
| 1933 Industries Inc. | -13.36 Million CAD | 70.31% |
| Red Light Holland Corp. | -7.62 Million CAD | 47.98% |
| Top Strike Resources Corp. | -1.72 Million CAD | -130.678% |
| Xebra Brands Ltd. | -1.95 Million CAD | -102.706% |
| Adastra Holdings Ltd. | -3.54 Million CAD | -11.936% |